Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2025-12-25 @ 3:08 AM
NCT ID:
NCT05444933
Eligibility Criteria:
Inclusion Criteria:
* Male or female ≥ 18 age at the time of cabozantinib initiation.
* Pathologically confirmed diagnosis of Renal Cell Carcinoma (RCC) considered as advanced at the time of cabozantinib initiation.
* Cabozantinib initiated from 1st March 2018 to 1st March 2021 for an advanced RCC.
* Cabozantinib initiated in 2nd line according to local Summary of Product Characteristics (SmPC).
Exclusion Criteria:
* Participant medical file without documented follow-up visits (post-cabozantinib initiation).
* Participant alive at study initiation who is opposed to data collection.
* Participant who died before study initiation and who was opposed to data collection for research purposes when alive.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05444933
Study Brief:
Protocol Section:
NCT05444933